U.S. flag

An official website of the United States government

NM_000143.4(FH):c.704A>G (p.His235Arg) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 29, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001784597.12

Allele description [Variation Report for NM_000143.4(FH):c.704A>G (p.His235Arg)]

NM_000143.4(FH):c.704A>G (p.His235Arg)

Gene:
FH:fumarate hydratase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q43
Genomic location:
Preferred name:
NM_000143.4(FH):c.704A>G (p.His235Arg)
HGVS:
  • NC_000001.11:g.241508637T>C
  • NG_012338.1:g.16118A>G
  • NM_000143.4:c.704A>GMANE SELECT
  • NP_000134.2:p.His235Arg
  • LRG_504t1:c.704A>G
  • LRG_504:g.16118A>G
  • NC_000001.10:g.241671937T>C
  • NM_000143.3:c.704A>G
Protein change:
H235R
Links:
dbSNP: rs1659990191
NCBI 1000 Genomes Browser:
rs1659990191
Molecular consequence:
  • NM_000143.4:c.704A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001211095Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 29, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.

Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefèvre S, Perrier-Trudova V, Rustin P, Barrois M, Slama A, Avril MF, Bessis D, Caron O, Caux F, Collignon P, Coupier I, Cremin C, Dollfus H, Dugast C, Escudier B, Faivre L, Field M, Gilbert-Dussardier B, et al.

J Med Genet. 2011 Apr;48(4):226-34. doi: 10.1136/jmg.2010.085068. Epub 2011 Mar 12. Erratum in: J Med Genet. 2011 Aug;48(8):576.

PubMed [citation]
PMID:
21398687

Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Kamai T, Tomosugi N, Abe H, Kaji Y, Oyama T, Yoshida K.

Int J Mol Sci. 2012 Nov 8;13(11):14518-32. doi: 10.3390/ijms131114518.

PubMed [citation]
PMID:
23203078
PMCID:
PMC3509594
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001211095.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 235 of the FH protein (p.His235Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hereditary leiomyomatosis and renal cell cancer (HLRCC) (PMID: 21398687). This variant is also known as c.575A>G (p.His192Arg). ClinVar contains an entry for this variant (Variation ID: 844336). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FH protein function with a positive predictive value of 95%. This variant disrupts the p.His235 amino acid residue in FH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23203078, 26983443). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024